Selenium supplementation and lung cancer incidence: An update of the nutritional prevention of cancer trial

Cancer Epidemiology Biomarkers and Prevention

Volumn 11, Issue 11, 2002, Pages 1285-1291

  Reid, Mary E ^a   Duffield Lillico, Anna J ^b   Garland, Linda ^b   Turnbull, Bruce W ^c   Clark, Larry C ^c   Marshall, James R ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c School of Operations Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SELENIUM;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CHEMOPROPHYLAXIS; DIET SUPPLEMENTATION; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NUTRITION; PRIORITY JOURNAL; SMOKING;

AGED; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NUTRITION PHYSIOLOGY; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SELENIUM; SMOKING; TREATMENT OUTCOME; UNITED STATES;

EID: 0036846660     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Combs, G. F., Jr., and Combs, S. B. Selenium and cancer. In: G. F. Combs, Jr. and S. B. Combs (eds.), The Role of Selenium in Nutrition Chapter 10, pp. 413-462. San Diego, CA: Academic Press, 1986
2. Patterson, B. H., and Levander, O. A. Naturally occurring selenium compounds in cancer chemoprevention trials: A workshop summary. Cancer Epidemiol. Biomark. Prey., 6, 63-69, 1997
3. Shamberger, R. J., and Frost, D. V. Possible protective effect of selenium against human cancer. Can. Med. Assoc. J., 100: 682-686, 1969
4. Schrauzer, G. N. Cancer mortality correlation studies. II. Regional associations of mortalities with the consumptions of foods and other commodities. Med. Hypotheses, 2: 39-49, 1976
5. Clark, L. C. The epidemiology of selenium and cancer. Fed. Proc., 44: 2584-2589, 1985
6. Yu, S-Y., Chu, Y-J., Gong, X-L., Hou, C., Li, W-G., Gong, H-M., and Xie, J-R. Regional variation of cancer mortality incidence and its relation to selenium levels in China. Biol. Trace Elem. Res., 7: 21-29, 1985
7. Combs, G. F., Jr., and Clark, L. C. Selenium and Cancer. Nutritional Oncology, pp. 215-222: Academic Press, San Diego, CA, 1999
8. Willett, W. C., Polk, B. F., Morris, J. S., Stampfer, M. J., Pressel, S., Rosner, B., Taylor, J. O., Schneider, K., and Hames, C. G. Prediagnostic serum selenium and risk of cancer. Lancet, 2: 130-134, 1983
9. Knekt, P., Aromaa, A., Maatela, J., Alfthan, G., Aaran, R. K., Hakama, M., Hakulinen, T., Peto, R., and Teppo, L. Serum selenium and subsequent risk of cancer among Finnish men and women. J. Natl. Cancer Inst., 82: 864-868, 1990
10. Coates, R. J., Weiss, N. S., Daling, J. R., Morris, J. S., and Labbe, R. F. Serum levels of selenium and retinol and the subsequent risk of cancer. Am. J. Epidemiol., 128: 515-523, 1988
11. Peleg, I., Morris, S., and Hames, C. G. Is serum selenium a risk factor for cancer? Med. Oncol. Tumor Pharm., 2: 157-163, 1985
12. Salonen, J. T., Salonen, R., Lappetelainen, R., Maenpaa, P. H., Alfthan, G., and Puska, P. Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: matched case-control analysis of prospective data. Br. Med. J. (Clin. Res. Ed.), 290: 417-420, 1985
13. Salonen, J. T., Alfthan, G., Huttunen, J. K., and Puska, P. Association between serum selenium and the risk of cancer. Am. J. Epidemiol., 120: 342-349, 1984
14. Kok, F. J., de Bruijn, A. M., Hofman, A., Vermeeren, R., and Valkenburg, H. A. Is serum selenium a risk factor for cancer in men only? Am. J. Epidemiol., 125: 12-16, 1987
15. Virtamo, J., Valkeila, E., Alfthan, G., Punsar, S., Huttunen, J. K., and Karvonen, M. J. Serum selenium and risk of cancer. A prospective follow-up of nine years. Cancer (Phila.), 60: 145-148, 1987
16. Ringstad, J., Jacobsen, B. K., Tretli, S., and Thomassen, Y. Serum selenium concentration associated with risk of cancer. J. Clin. Pathol., 41: 454-457, 1988
17. Menkes, M. S., Comstock, G. W., Vuilleumier, J. P., Helsing, K. J., Rider, A. A., and Brookmeyer, R. Serum β-carotene, vitamins A and E, selenium, and the risk of lung cancer. N. Engl. J. Med., 315: 1250-1254, 1986
18. Nomura, A., Heilbrun, L. K., Morris, J. S., and Stemmermann, G. N. Serum selenium and the risk of cancer, by specific sites: Case-control analysis of prospective data. J. Natl. Cancer Inst., 79: 103-108, 1987
19. Criqui, M. H., Bangdiwala, S., Goodman, D. S., Blaner, W. S., Morris, J. S., Kritchevsky, S., Lippel, K., Mebane, I., and Tyroler, H. A. Selenium, retinol, retinol-binding protein, and uric acid. Associations with cancer mortality in a population-based prospective case-control study. Ann. Epidemiol., 1: 385-393, 1991
20. Kabuto, M., Imai, H., Yonezawa, C., Neriishi, K., Akiba, S., Kato, H., Suzuki, T., L., and Blot, W. J. Prediagnostic serum selenium and zinc levels and subsequent risk of lung and stomach cancer in Japan. Cancer Epidemiol. Biomark. Prev., 3, 465-469, 1994
21. Comstock, G. W., Alberg, A. J., Huang, H. Y., Wu, K., Burke, A. E., Hoffman, S. C., Norkus, E. P., Gross, M., Cutler, R. G., Morris, J. S., Spate, V. L., and Helzlsouer, K. J. The risk of developing lung cancer associated with antioxidants in the blood: Ascorbic acid, carotenoids, α-tocopherol, selenium, and total peroxyl radical absorbing capacity. Cancer Epidemiol. Biomark. Prev., 6: 907-916, 1997
22. Knekt, P., Marniemi, J., Teppo, L., Heliovaara, M., and Aromaa, A. Is low selenium status a risk factor for lung cancer? Am. J. Epidemiol., 148: 975-982, 1998
23. van den Brandt, P. A., Goldbohm, R. A., van't Veer, P., Bode, P., Dorant, E., Hermus, R. J., and Sturmans, F. A prospective cohort study on selenium status and the risk of lung cancer. Cancer Res., 53: 4860-4865, 1993
24. Garland, M., Morris, J. S., Stampfer, M. J., Colditz, G. A., Spate, V. L., Baskett, C. K., Rosner, B., Speizer, F. E., Willett, W. C., and Hunter, D. I. Prospective study of toenail selenium levels and cancer among women. J. Natl. Cancer Inst., 87: 497-505, 1995
25. Knekt, P., Jarvinen, R., Seppanen, R., Rissanen, A., Aromaa, A., Heinonen, O. P., Albanes, D., Heinonen, M., Pukkala, E., and Teppo, L. Dietary antioxidants and the risk of lung cancer. Am. J. Epidemiol., 134: 471-479, 1991
26. Clark, L. C., Combs, G. F., Jr., Turnbull, B. W., Slate, E. H., Chalker, D. K., Chow, J., Davis, L. S., Glover, R. A., Graham, G. F., Gross, E. G., Krongrad, A., Lesher, J. L. J., Park, H. K., Sanders, B. B. J., Smith, C. L., and Taylor, J. R. for the Nutritional Prevention of Cancer Study Group. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. JAMA, 276: 1957-1963, 1996
27. Mountain, C. F. The international system for staging lung cancer. Semin. Surg. Oncol., 18: 106-115, 2000
28. STATA Statistical Software Version 6.0. College Station, TX: STATA Corporation, 1999
29. Jemal, A., Thomas, A., Murray, T., and Thun, M. Cancer statistics, 2002. CA Cancer J. Clin., 52: 23-47, 2002
30. Virmani, A. K., Fong, K. M., Kodagoda, D., McIntire, D., Hung, J., Tonk, V., Minna, J. D., and Gazdar, A. F. Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types. Genes Chromosomes Cancer, 2: 308-319, 1998
31. Minna, J. D. Genetic events in the pathogenesis of lung cancer, Chest, 96: 17S-23S, 1989
32. Thiberville, L., Payne, P., Vielkinds, J., LeRiche, J., Horsman, D., Nouvet, G., Palcic, B., and Lam, S. Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus. Cancer Res., 55: 5133-5139, 1995
33. Hirsch, F. R., Franklin, W. A., Gazdar, A. F., and Bunn, P. A. Early detection of lung cancer: Clinical perspectives of recent advances in biology and radiology. Clin. Cancer Res., 7: 5-22, 2001
34. Franklin, W. A. Pathology of lung cancer. J. Thorac. Imaging, 15: 3-12, 2000
35. Tormanen, U., Nuorva, K., Soini, Y., and Paakko, P. Apoptotic activity is increased in parallel with the metaplasia-dysplasia-carcinoma sequence of the bronchial epithelium. Br. J. Cancer, 79: 996-1002, 1999
36. WHO. Histological Typing of Lung Tumors, International Classification of Tumors. Geneva: 1981
37. Hu, G., and Cassano, P. A. Antioxidant nutrients and pulmonary function: The Third National Health and Nutrition Examination Survey (NHANES III). Am. J. Epidemiol., 151: 975-981, 2000
38. Hill, K. E., Xia, Y., Akesson, B., Boeglin, M. E., and Burk, R. F. Seleno-protein P concentration in plasma is an index of selenium status in selenium-deficient and selenium-supplemented Chinese subjects. J. Num., 126: 138-145, 1996
39. Duffield, A. J., Thomson, C. D., Hill, K. E., and Williams, S. An estimation of selenium requirements for New Zealanders. Am. J. Clin. Nutr., 70: 896-903, 1999
40. El-Bayoumy, K. The protective role of selenium on genetic damage and on cancer. Mutat. Res., 475: 123-139, 2001
41. Baylin, S. B., Herman, J. G., Graff, J. R., Vertino, P. M., and Issa, J. P. Alterations in DNA methylation: A fundamental aspect of neoplasia. Adv. Cancer Res., 72: 141-196, 1998
42. Esteller, M., Corn, P. G., Urena, J. M., Gabrielson, E., Baylin, S. B., and Herman, J. G. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. Cancer Res., 58: 4515-4518, 1998
43. Bachman, K. E., Herman, J. G., Corn, P. G., Merlo, A., Costello, J. F., Cavenee, W. K., Baylin, S. B., and Graff, J. R. Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers. Cancer Res., 59: 798-802, 1999
44. Esteller, M., Hamilton, S. R., Burger, P. C., Baylin, S. B., and Herman, J. G. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res., 59: 793-797, 1999
45. Zochbauer-Muller, S., Fong, K. M., Virmani, A. K., Geradts, J., Gazdar, A. F., and Minna, J. D. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res., 61: 249-5255, 2001
46. Merto, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1: 686-692, 1995
47. Virmani, A. K., Rathi, A., Zochbauer-Muller, S., Sacchi, N., Fukuyama, Y., Bryant, D., Maitra, A., Heda, S., Fong, K. M., Thunnissen, F., Minna, J. D., and Gazdar, A. F. Promoter methylation and silencing of the retinoic acid receptor-β gene in lung carcinomas. J. Natl. Cancer Inst., 92: 1303-1307, 2000
48. Kashiwabara, K., Oyama, T., Sano, T., Fukuda, T., and Nakajima, T. Correlation between methylation status of the p16/CDKN2 gene and the expression of p16 and Rb proteins in primary non-small cell lung cancers. Int. J. Cancer, 79: 215-220, 1998
49. Esteller, M., Sanchez-Cespedes, M., Rosell, R., Sidransky, D., Baylin, S. B., and Herman, J. G. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res., 59: 67-70, 1999
50. Ganther, H. E. Pathways of selenium metabolism including respiratory excretory products. J. Am. Coll. Toxicol., 5: 1-5, 1986
51. Fiala, E. S., Staretz, M. E., Pandya, G. A., El-Bayoumy, K., and Hamilton, S. R. Inhibition of DNA cytosine methyltransferase by chemopreventive selenium compounds, determined by an improved assay for DNA cytosine methyltransferase and DNA cytosine methylation. Carcinogenesis (Lond.), 19: 597-604, 1998
52. Cox, R. Studies on DNA methyltransferase and alteration of the enzyme activity by chemical carcinogens. Toxicol. Pathol., 14: 477-482, 1986
53. Wolff, H., Saukkonen, K., Anttila, S., Karjalainen, A., Vainio, H., and Ristimaki, A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res., 58: 4997-5001, 1998
54. Hida, T., Yatabe, Y., Achiwa, H., Muramatsu, H., Kozaki, K., Nakamura, S., Ogawa, M., Mitsudomi, T., Sugiura, T., and Takahashi, T. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res., 58: 3761-3764, 1998
55. Ochiai, M., Oguri, T., Isobe, T., Ishioka, S., and Yamakido, M. Cyclooxygenase-2 (COX-2) mRNA expression levels in normal lung tissues and non-small cell lung cancers. Jpn. J. Cancer Res., 90: 1338-1343, 1999
56. Achiwa, H., Yatabe, Y., Hida, T., Kuroishi, T., Kozaki, K., Nakamura, S., Ogawa, M., Sugiura, T., Mitsudomi, T., and Takahashi, T. Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas. Clin. Cancer Res., 5: 1001-1005, 1999
57. Hosomi, Y., Yokose, T., Hirose, Y., Nakajima, R., Nagai, K., Nishiwaki, Y., and Ochiai, A. Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung. Lung Cancer, 30: 73-81, 2000
58. Soslow, R. A., Dannenberg, A. J., Rush, D., Woerner, B. M., Khan, K. N., Masferrer, J., and Koki, A. T. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer (Phila.), 89: 2637-2645, 2000
59. Tsujii, M., and DuBois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83: 493-501, 1995
60. Sawaoka, H., Kawano, S., Tsuji, S., Tsujii, M., Murata, H., and Hori, M. Effects of NSAIDs on proliferation of gastric cancer cells in vitro: Possible implication of cyclooxygenase-2 in cancer development. J. Clin. Gastroenterol., 27(Suppl. 1): S47-S52, 1998
61. Form, D. M., and Auerbach, R. PGE2 and angiogenesis. Proc. Soc. Exp. Biol. Med., 172: 214-218, 1983
62. Seed, M. P. Angiogenesis inhibition as a drug target for disease: An update. Expert Opin. Investig. Drugs, 5: 1717-1737, 1996
63. Marnett, L. J. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res., 52: 5575-5589, 1992
64. Redman, C., Xu, M. J., Peng, Y. M., Scott, J. A., Payne, C., Clark, L. C., and Nelson, M. A. Involvement of polyamines in selenomethionine induced apoptosis and mitotic alterations in human tumor cells. Carcinogenesis (Lond.), 18: 1195-202, 1997
65. Greeder, G. A., and Milner, J. A. Factors influencing the inhibitory effect of selenium on mice inoculated with Ehrlich ascites tumor cells. Science (Wash. DC), 209: 825-827, 1980
66. Combs, G. F., Jr. Chemopreventive mechanisms of selenium. Med. Klin., 94(Suppl. 3): 18-24, 1999
67. Milner, J. A., and Hsu, C. Y. Inhibitory effects of selenium on the growth of L1210 leukemic cells. Cancer Res., 41: 1652-1656, 1981
68. Watrach, A. M., Milner, J. A., and Watrach, M. A. Effect of selenium on growth rate of canine mammary carcinoma cells in athymic nude mice. Cancer Lett., 15: 137-143, 1982
69. Khuri, F. R., and Lippman, S. M. Lung cancer chemoprevention. Semin. Surg. Oncol., 18: 100-105, 2000
70. Goodman, G. E. Prevention of lung cancer. Curr. Opin. Oncol., 10: 122-126, 1998